10-05/06 :: May/June 2010
quarter of 2009 to $2.1 million in the first quarter of 2010, while total revenue decreased by 7%, from $8.5 million in the first quarter of 2009 to $7.9 milli- on in the first quarter of 2010. The decrease in total revenue was largely the result of lower pass-through costs for subcontracts and materials under a research contract in the company’s technology development business segment. The company reported a net loss attributable to common shareholders of $1.3 million, or $0.10 per common share, for the first quarter of 2010, as compared to a net loss of $40.9 million, or $3.66 per common share for the first quarter of 2009. The company consummated a settlement of its litigation with Hansen and emerged from Chap- ter 11 reorganization in January 2010. http://www.lunainnovations.com
agForce Nanotechnologies AG (FSE: MF6 / Bloomberg: MF6:GR), a German medical
technology company, announced its intention to increase its share capital under the procedure to exclude subscription rights for existing investors. The company’s nominal capital is EUR3,773,198.00, divided into 3,773,198 common shares in bearer form with an imputed nominal value of EUR1.00. In its resolution of the June 16, 2010, approved by the supervisory board on June 16, 2010, the executive board of MagForce Nanotechnologies has decided to increase its share capital by up to EUR80,190 against cash contributions, bringing its approved capital limit up to EUR3,853,388.
Up to 80,190 new common shares will be issued, with profit participation rights dating from January 1, 2009. The company has excluded subscription rights to existing shareholders by its authority under sec. 6 para. 3 of its articles of incorporation (Satzung). The
new shares will be privately placed with German and international institutional investors at an offering pri- ce of EUR42.00 per share. The proceeds of the capi- tal increase are to be used to finance the company’s further growth. http://www.magforce.de
or SID Display Week in Seattle, Merck KGaA (Bloomberg: MRK:GR), Germany, has selected
the heading green3 to denote the extent to which its materials help the environment. Specifically, green3 stands for producing eco-friendly materials, enabling eco-friendly manufacturing processes, and reducing the energy consumption of the devices that contain them. Merck presented its advanced PS-VA materi- als for high-quality LCDs. PS-VA (Polymer Stabilized Vertical Alignment) is a novel premium LC technolo- gy that offers better contrast, faster switching speed and reduces power consumption in LCD televisions. It is an innovation based on VA, the leading LCD television technology besides IPS (in plane swit- ching). Merck PS-VA materials, which are part of the company’s innovative licristal®
portfolio, are based
on a combination of liquid crystals with specially designed reactive mesogens produced in a sophisti- cated production process.
Furthermore, Merck provided information on its liquid crystal materials for a switchable Blue Phase, which is seen as a future technology for fast swit- ching, high contrast ratio and wide viewing angle. Cost effective production is predicted due to the cell layout without alignment layers and no constant cell gap required. The extended livilux®
des a complete new set of electron, hole transport and matrix (host) materials for small molecule-based OLEDs. These materials enable display and lighting
range now inclu-